AINDEX
Markets

Enovis Corporation (ENOV)

ENOVNYSEIndustrial Specialties

$28.54

+1.38 (+5.08%) today

Closed, Nov 9, 4:00 PM ET

+5.08% 1D
Market cap
$1.65bn
P/E
8.4
EPS, last 4 quarters
$3.38
Dividend yield
–
Day range
–
52-week range
$16.70 to $32.41
Average volume
–
Previous close
$27.16

Analysts

11 covering

Buy10 buy, 1 hold, 0 sell

Targets a year out average $39.13, +37.1% from here

$31.00now $28.54$47.00

Earnings

next estimate $0.9500

Next report

Dec 2025

+17.3%

Mar 2026

+8.5%

Jun 2026

-3.8%

Sep 2026

+21.9%

estimate reported, and the surprise

Financials

QuarterDec 2025Apr 2026Jul 2026Oct 2026
Revenue$575.76m$589.15m$582.78m$558.73m
Gross profit$349.42m$365.49m$359.25m$339.85m
Operating income-$502.18m$6.53m$17.41m$3.38m
Net income-$520.59m-$8.76m-$1.19m$3.14m

Last four quarters: revenue $2.31bn, margin -22.9%, free cash flow $69.56m

News

8 latest

The company

Enovis (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. We partner with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. Enovis solutions impact the well-being of millions of patients wherever they are on their pathway to health. Discover more about Enovis at www.enovis.com.

Sector
Health Care
Industry
Industrial Specialties
Exchange
NYSE
Region
North America
Website
enovis.com

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.

Enovis Corporation (ENOV) price, chart and news · AINDEX